P-GLYCOPROTEIN-MEDIATED MULTIDRUG-RESISTANCE IN TUMOR-CELLS - BIOCHEMISTRY, CLINICAL RELEVANCE AND MODULATION

被引:80
作者
SHUSTIK, C
DALTON, W
GROS, P
机构
[1] ROYAL VICTORIA HOSP,MCGILL CANC CTR,MONTREAL,PQ H3A 1A1,CANADA
[2] ROYAL VICTORIA HOSP,DEPT MED,MONTREAL,PQ H3A 1A1,CANADA
[3] UNIV ARIZONA,TUCSON,AZ
[4] ARIZONA CANC CTR,TUCSON,AZ
[5] MCGILL UNIV,DEPT BIOCHEM,MONTREAL,PQ,CANADA
关键词
D O I
10.1016/0098-2997(94)00040-A
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
[No abstract available]
引用
收藏
页码:1 / &
相关论文
共 293 条
[1]   THE MULTIDRUG RESISTANCE (MDR1) GENE-PRODUCT FUNCTIONS AS AN ATP CHANNEL [J].
ABRAHAM, EH ;
PRAT, AG ;
GERWECK, L ;
SENEVERATNE, T ;
ARCECI, RJ ;
KRAMER, R ;
GUIDOTTI, G ;
CANTIELLO, HF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (01) :312-316
[2]  
AKIYAMA SI, 1988, MOL PHARMACOL, V33, P144
[3]  
ALSHAWI MK, 1993, J BIOL CHEM, V268, P4197
[4]   PARTIAL-PURIFICATION AND RECONSTITUTION OF THE HUMAN MULTIDRUG-RESISTANCE PUMP - CHARACTERIZATION OF THE DRUG-STIMULATABLE ATP HYDROLYSIS [J].
AMBUDKAR, SV ;
LELONG, IH ;
ZHANG, JP ;
CARDARELLI, CO ;
GOTTESMAN, MM ;
PASTAN, I .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (18) :8472-8476
[5]  
AMES GFL, 1986, ANNU REV BIOCHEM, V55, P397, DOI 10.1146/annurev.biochem.55.1.397
[6]  
ARCECI RJ, 1993, CANCER RES, V53, P310
[7]   THE GENE ENCODING MULTIDRUG RESISTANCE IS INDUCED AND EXPRESSED AT HIGH-LEVELS DURING PREGNANCY IN THE SECRETORY EPITHELIUM OF THE UTERUS [J].
ARCECI, RJ ;
CROOP, JM ;
HORWITZ, SB ;
HOUSMAN, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (12) :4350-4354
[8]   DISCRETE MUTATIONS INTRODUCED IN THE PREDICTED NUCLEOTIDE-BINDING SITES OF THE MDR1 GENE ABOLISH ITS ABILITY TO CONFER MULTIDRUG RESISTANCE [J].
AZZARIA, M ;
SCHURR, E ;
GROS, P .
MOLECULAR AND CELLULAR BIOLOGY, 1989, 9 (12) :5289-5297
[9]   MULTIDRUG RESISTANCE IN ACUTE MYELOID-LEUKEMIA [J].
BAER, MR ;
BLOOMFIELD, CD .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1991, 83 (10) :663-665
[10]   PHASE-I TRIAL OF DOXORUBICIN WITH CYCLOSPORINE AS A MODULATOR OF MULTIDRUG-RESISTANCE [J].
BARTLETT, NL ;
LUM, BL ;
FISHER, GA ;
BROPHY, NA ;
EHSAN, MN ;
HALSEY, J ;
SIKIC, BI .
JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (04) :835-842